15% off first order with code: 1storder
Tirzepatide, developed by Pharma Lab Global Brazil, is an innovative and synthetic dual GIP and GLP-1 receptor agonist. It mimics the biological activity of native glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), by interacting with their respective receptors.
This unique characteristic opens up new avenues for exploring the functions of these peptides in various physiological processes. It holds immense promise in uncovering potential therapeutic pathways for conditions such as diabetes and obesity. Available as a peptide vial, Tirzepatide from Pharma Lab Global Brazil offers flexibility and ease of use for diversified research explorations.